Evidence map›Paper›PMID 30170389›Full record

Trial reportMedicine2018

Impact of cigarette smoking cessation on plasma α-klotho levels.

Yoko Kamizono, Yuhei Shiga, Yasunori Suematsu, Satoshi Imaizumi, Hitomi Tsukahara, Keita Noda, Takashi Kuwano, Kanta Fujimi, Keijiro Saku, Shin-Ichiro Miura

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yoko KamizonoInternational University of Health and Welfare Department of Cardiology Clinical Research and Ethics Center, Fukuoka University School of Medicine Fukuoka University School of Nursing Clinical Research Assist Center Division of Rehabilitation, Fukuoka University Hospital Department of Molecular Cardiovascular Therapeutics, Fukuoka University School of Medicine, Fukuoka, Japan.
Yuhei Shiga
Yasunori Suematsu
Satoshi Imaizumi
Hitomi Tsukahara
Keita Noda
Takashi Kuwano
Kanta Fujimi
Keijiro Saku
Shin-Ichiro Miura
Fukuoka University · JPFukuoka University Hospital · JPInternational University of Health and Welfare · JPSeoul School of Integrated Sciences and Technologies · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking cessation reduces the risk of cardiovascular disease and improves clinical outcomes. We studied the effect of smoking cessation on plasma levels of α-klotho, which is an antiaging protein. We treated 28 smokers (male:female = 23:5, 46 ± 12 years) with varenicline (n = 14) or a transdermal nicotine patch (n = 14) as part of a 12-week smoking cessation program (the VN-SEESAW Study). Pulse rate, blood pressure, plasma levels of α-klotho, fibroblast growth factor (FGF)-19, FGF-21, hemoglobin (Hb), and expiratory carbon monoxide (CO) concentration were measured before and after the antismoking intervention. Smoking cessation significantly decreased pulse rate, α-klotho, Hb, and CO concentration, but not FGF-19 or FGF-21 in all subjects. On the contrary, body mass index significantly increased after the intervention. Changes in α-klotho levels (values at week 12 - values at week 0) were negatively associated with α-klotho levels at week 0 and positively associated with changes in Hb levels. In addition, the successful smoking cessation group (n = 21) showed significant reductions in pulse rate, systolic blood pressure, α-klotho, Hb, and CO concentration. In conclusion, smoking cessation significantly decreased serum levels of the antiaging molecule α-klotho. Our results are consistent with a previous report that an increase in α-klotho might be a compensatory response to smoking stress.

Indexed as

AdultBlood PressureCardiovascular DiseasesCigarette SmokingFemaleFibroblast Growth FactorsGlucuronidaseHeart RateHumansKlotho ProteinsMaleMiddle AgedNicotinic AgonistsRisk FactorsSmoking CessationTobacco Use Cessation DevicesFGF19 protein, humanfibroblast growth factor 21Fibroblast Growth FactorsGlucuronidaseKlotho ProteinsNicotinic AgonistsVarenicline

Identifiers

PMID30170389
PMCPMC6392581
OpenAlexW2889486540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.